Marvell Technology, Inc. (MRVL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 209.32 |
| Open | 202.91 |
| Day High | 206.07 |
| Day Low | 191.29 |
| 52-Week High | 329.88 |
| 52-Week Low | 61.44 |
| Volume | 19.71M |
| Average Volume | 41.28M |
| Market Cap | 170.1B |
| PE | 64.1 |
| EPS | 3.03 |
| Moving Average 50 Days | 239.15 |
| Moving Average 200 Days | 132.8 |
| Change | -15.09 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX